Balfour Beatty heads into the week of May 28 with a quiet but telling gap opening up between its own price action and a broadly rising peer group — and with the CEO and CFO having sold meaningful chunks of stock in April.
The insider activity is the most concrete signal in this week's setup. Both executives moved to reduce holdings after receiving share awards. CEO Philip Hoare sold 121,214 shares at £7.99 on April 8, raising just over £968,000. CFO Phil Harrison sold 109,744 shares the same day at the same price, pocketing roughly £877,000. Harrison had also sold 47,785 shares at £7.47 on March 31. The sales followed award grants on April 3 and March 31 — a pattern consistent with routine post-vesting disposals — but the timing stands out given the stock has since drifted lower, closing at £7.905 on May 27. Net insider activity over the past 90 days reflects 278,743 shares acquired on balance, but the bulk of that is award grants at zero cost rather than open-market buying. The one genuine open-market purchase in the recent data was CEO Hoare buying 39,459 shares at £6.30 back in September 2025 — well below current levels.
The peer picture makes the underperformance harder to ignore. Construction and infrastructure names across Europe have had a strong week. Amsterdam-listed BAMNB gained over 13% in the past seven days. Madrid-listed and each added more than 6%. LSE-listed peer rose 5.4%. Balfour Beatty, by contrast, lost just under 0.9% on the week and 1.9% over the past month. The sector appears to be catching a bid — Balfour Beatty is not sharing in it.
Short interest is not the driver here. The SI % of FF sits at just 0.1%, effectively negligible, and has oscillated between 0.05% and 0.25% across the past six weeks with no directional conviction. The borrow market remains extremely loose — availability is uncapped, meaning there are far more shares available to lend than there are shorts in the stock. Cost to borrow has risen about 28% over the past week to 0.72%, but that is still a very low absolute level and well below the spike to 2.26% seen on April 9. There is no meaningful short pressure here, and no squeeze dynamic to speak of.
What analysts make of the stock offers some comfort, though the data is not fresh enough to be definitive. The consensus rating is a buy, with five buy recommendations against four holds as of mid-May. No recent rating changes are recorded in the snapshot. The ORTEX stock score tells a more cautious story: the value component scores near the floor at 11, suggesting the market is not pricing the stock cheaply on most standard measures. The PE multiple has compressed about 3% over the past 30 days, drifting toward 15.1x, and EV/EBITDA has slipped to 7.3x. The dividend score ranks in the 90th percentile — a function of the company's payout history — though the dividend data in the snapshot is stale, with the most recent declared payment dating to early 2022. Investors should verify the current dividend policy independently.
The full-year results in March delivered a strong reaction: the stock jumped over 8% on the day and added another 11% across the following five days. That print reset expectations upward. The next scheduled event is the half-year results, pencilled in for August 12. Between now and then, the clearest thing to watch is whether Balfour Beatty begins to recapture the momentum running through the broader European infrastructure sector — or whether the relative underperformance deepens.
See the live data behind this article on ORTEX.
Open BBY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
Best Buy has shed 11.2% in a single week, closing at $59.11 — its lowest level in months — as consumer electronics retailers bear the brunt of renewed tariff anxiety and softening big-ticket demand. The week's move…
